New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
13:15 EDTPCRX, PCRXBarclays' pharmaceuticals analyst research team holds a conference call
Pharmaceuticals Research Team, along with Dr. Stephen Cohen of Emory University School of Medicine, dicuss Pacira Pharmaceuticals' Exparel on an Analyst/Industry conference call to be held on February 1 at 1:30 pm.
News For PCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 5, 2015
07:54 EDTPCRXFDA PDUFA Date for Pacira's Exparel is March 5, 2015
March 4, 2015
08:44 EDTPCRXPacira shares oversold after CRL pullback, says Brean Capital
Brean Capital believes Pacira shares are oversold following the pullback after the company received a Complete Response Letter from the FDA for its nerve block drug, Exparel. The firm feels even if there was a delay in the drug by two years the company can still support a higher valuation. Brean Capital reiterated its Buy rating but lowered its price target to $121 from $135 on Pacira shares.
March 3, 2015
08:09 EDTPCRXPacira price target lowered to $128 from $163 at Canaccord
Subscribe for More Information
March 2, 2015
09:22 EDTPCRXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Amira Nature Foods (ANFI), up 8.6%... Stratasys (SSYS), up 3.6%... Magnum Hunter (MHR), up 3%. ALSO HIGHER: Mavenir Systems (MVNR), up 19.1% after Mitel (MITL) agrees to acquire Mavenir Systems for $560M... Athersys (ATHX), up 19.7% following license agreement and collaboration with Chugai... OHR Pharmaceutical (OHRP), up 11.4% following additional positive data from OHR-102 IMPACT study... NXP Semiconductors (NXPI), up 14% following merger agreement with Freescale Semiconductor (FSL). Freescale Semiconductor is up 9.1%... Mast Therapeutics (MSTX), up 7.7% following positive results from Vepoloxamer study. DOWN AFTER EARNINGS: JinkoSolar (JKS), down 4.7%... Scorpio Tankers (STNG), down 4.5%. ALSO LOWER: Lumber Liquidators (LL), down 24.2% following CBS' 60 Minutes says that the company is linked to health and safety violations... Aruba Networks (ARUN), down 1.7% after HP (HPQ) confirms deal to acquire Aruba Networks for $24.67... Pacira Pharmaceuticals (PCRX), down 14.4% after receiving complete response letter from FDA for sNDA in use of Exparel... (WBAI), down 14.4% after announcing that temporary suspension will adversely impact financial results.
06:33 EDTPCRXPacira receives complete response letter from FDA for sNDA in use of Exparel
Subscribe for More Information
February 26, 2015
10:00 EDTPCRXOn The Fly: Analyst Downgrade SummaryStarz
Subscribe for More Information
07:43 EDTPCRXPacira downgraded at BofA/Merrill
Subscribe for More Information
06:17 EDTPCRXPacira downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
February 25, 2015
07:26 EDTPCRXPacira price target raised to $135 from $111 at Brean Capital
Subscribe for More Information
February 24, 2015
06:43 EDTPCRXPacira sees FY15 Exparel revenue $310M-$330M
Subscribe for More Information
06:42 EDTPCRXPacira reports Q4 non-GAAP EPS 35c, consensus 28c
Reports Q4 revenue $61.8M, consensus $62.12M

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use